Zacks Research Issues Negative Outlook for BIO Earnings
Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Equities researchers at Zacks Research reduced their Q1 2025 EPS estimates for shares of Bio-Rad Laboratories in a research report issued on Thursday, March 6th. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings per share of $1.98 for the quarter, […]
Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Equities researchers at Zacks Research reduced their Q1 2025 EPS estimates for shares of Bio-Rad Laboratories in a research report issued on Thursday, March 6th. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings per share of $1.98 for the quarter, […]
